ZA200507552B - Medicament for the treatment of respiratory tract disorders - Google Patents
Medicament for the treatment of respiratory tract disorders Download PDFInfo
- Publication number
- ZA200507552B ZA200507552B ZA200507552A ZA200507552A ZA200507552B ZA 200507552 B ZA200507552 B ZA 200507552B ZA 200507552 A ZA200507552 A ZA 200507552A ZA 200507552 A ZA200507552 A ZA 200507552A ZA 200507552 B ZA200507552 B ZA 200507552B
- Authority
- ZA
- South Africa
- Prior art keywords
- medicament
- plant material
- respiratory tract
- medicament according
- tract disorders
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims description 43
- 208000018569 Respiratory Tract disease Diseases 0.000 title claims description 20
- 241000196324 Embryophyta Species 0.000 claims description 33
- 239000000463 material Substances 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000010883 coal ash Substances 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 241001635500 Linzia glabra Species 0.000 claims description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 8
- 239000002956 ash Substances 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 239000005720 sucrose Substances 0.000 claims description 8
- 206010011416 Croup infectious Diseases 0.000 claims description 7
- 208000019693 Lung disease Diseases 0.000 claims description 7
- 206010068319 Oropharyngeal pain Diseases 0.000 claims description 7
- 201000007100 Pharyngitis Diseases 0.000 claims description 7
- 208000006673 asthma Diseases 0.000 claims description 7
- 206010006451 bronchitis Diseases 0.000 claims description 7
- 201000010549 croup Diseases 0.000 claims description 7
- 235000003599 food sweetener Nutrition 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 description 2
- 230000007813 immunodeficiency Effects 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 244000261169 Coleus parviflorus Species 0.000 description 1
- 235000005602 Coleus parviflorus Nutrition 0.000 description 1
- 241001656007 Hypoxis hemerocallidea Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000020741 pine bark extract Nutrition 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
2 200¢ 75/0755, :
MEDICAMENT FOR THE TREATMENT OF RESPIRATORY TRACT
DISORDERS
This invention relates to a medicament for the treatment of respiratory tract disorders.
In this specification, the term ‘mammal’ includes within its scope, but is not limited to, humans.
Known compositions for the treatment of respiratory tract disorders usually contain chemical substances, many of which have a number of negative side effects to the user of the composition.
South African patent number ZA2003/8216 filed in the name of the applicant of this patent application, relates to a method and medicament for the treatment of immuno-deficiency conditions. The medicament comprises coal ash, grape seeds, pine bark extracts, a tincture of African potato (Hypoxis rooperi), calcium ascorbate and bioflavanoids. The medicament is effective in the treatment of immuno-deficiency conditions such as HIV/AIDS and cancer. The medicament improves and maintains the immune system of a user, reduces the frequency of opportunistic infections, accelerates healing and assists in the promotion of well-being.
The applicant has subsequently found that a medicament containing coal ash is an effective treatment for respiratory disorders when used together with certain plant material.
It is therefore an object of the present invention to provide a medicament for the treatment of respiratory tract disorders, which is a useful alternative to known compositions.
According to a first aspect of the invention there is provided a medicament for the treatment of respiratory tract disorders comprising a pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous).
The medicament may include from 0.2% to 20%, preferably 0.59% coal ash on a mass per mass basis.
The plant material of the plants of the species Vernonia glabra (phimatenous) may be in the form of roots, stems, and leaves.
The medicament may include ash of the plant material.
The medicament may include from 0.2% to 20%, preferably 0.59% ash of the plant material on a mass per mass basis.
The medicament may include any one or more of the following: a preservative; a suitable carrier; and a sweetener.
The medicament may further include any one or more of the following: alcohol as the preservative; glycerine as the carrier; and sucrose as the sweetener.
The alcohol may be between 90% and 98% pure alcohol, preferably 94.4% pure alcohol.
The medicament may include from 4% to 20%, preferably 14.12% alcohol on a mass per mass basis; from 10% to 60%, preferably 42.35% glycerine on a mass per mass basis; and from 10% to 60%, preferably 42.35% sucrose on a mass per mass basis.
The medicament may be effective in the treatment of any one or more respiratory tract disorders selected from the group consisting of asthma; flu; croup; bronchitis; sore throat; and lung diseases.
According to a second aspect of the invention there is provided a pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous) for use in the treatment of respiratory tract disorders. 5
The respiratory tract disorders may be selected from the group consisting of asthma; flu; croup; bronchitis; sore throat; and lung diseases.
According to a third aspect of the invention there is provided use of a pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous) in the preparation of a medicament for the treatment of respiratory tract disorders.
The respiratory tract disorders may be selected from the group consisting of asthma; flu; croup; bronchitis; sore throat; and lung diseases.
The invention will now be described further by way of a non-limiting example.
According to a preferred embodiment of the invention, a medicament for the treatment of respiratory tract disorders comprises a pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous). The plant material is in the form of ash of the roots, stems, and leaves of the plant of the species
Vernonia glabra (phimatenous).
The medicament includes from 0.2% to 20% coal ash on a mass per mass basis and from 0.2% to 20% ash of the plant material on a mass per mass basis.
The medicament further includes a preservative in the form of alcohol; a suitable carrier in the form of glycerine; and a sweetener in the form of sucrose.
The alcohol is between 90% and 98% pure alcohol, preferably 94.4% pure alcohol. The medicament include from 4% to 20% alcohol on a mass per mass basis; from 10% to 60% glycerine on a mass per mass basis; and from 10% to 60% sucrose on a mass per mass basis.
A volume of 1 ml of the medicament comprises the following:
The Vernonia glabra (phimatenous) ash and coal ash are active ingredients, and the glycerine, sucrose, and alcohol are inactive ingredients.
The medicament is in the form of a syrup which is administered to a mammal in need thereof. From 2 ml to 10 ml of the medicament is administered to the mammal two to three times daily.
The applicant has found that the medicament is effective in the treatment of any one or more respiratory tract disorders selected from the group consisting of asthma; flu; croup; bronchitis; sore throat; and lung diseases.
It will be appreciated that variations in detail are possible with a medicament for the treatment of respiratory tract disorders according to the invention without departing from the scope of the appended claims.
Claims (21)
1. A medicament for the treatment of respiratory tract disorders comprising a pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous).
2. A medicament according to claim 1 which includes from 0.2% to 20% coal ash on a mass per mass basis.
3. A medicament according to claim 2 which includes 0.59% coal ash on a mass per mass basis.
4. A medicament according to any one of the preceding claims wherein the plant material of the plants of the species Vernonia glabra (phimatenous) are in the form of roots, stems, and leaves.
5. A medicament according to any one of the preceding claims which includes ash of the plant material.
6. A medicament according to claim 5 which includes from 0.2% to 20% ash of the plant material on a mass per mass basis.
7. A medicament according to claim 6 which includes 0.59% ash of the plant material on a mass per mass basis.
8. A medicament according to any one of the preceding claims which includes any one or more of the following: a preservative; a suitable carrier; and a sweetener.
9. A medicament according to claim 8 which further includes any one or more of the following: alcohol as the preservative; glycerine as the carrier; and sucrose as the sweetener.
10. A medicament according to claim 9 wherein the alcohol is between 90% and 98% pure alcohol.
11. A medicament according to claim 10 wherein the alcohol is 94.4% pure alcohol.
12. A medicament according to any one of claims 9 to 11 which includes from 4% to 20% alcohol on a mass per mass basis; from 10% to 60% glycerine on a mass per mass basis; and from 10% to 60% sucrose on a mass per mass basis.
13. A medicament according to claim 12 which includes 14.12% alcohol on a mass per mass basis; 42.35% glycerine on a mass per mass basis; and 42.35% sucrose on a mass per mass basis.
14. A medicament according to any one of the preceding claims which is effective in the treatment of any one or more respiratory tract disorders selected from the group consisting of asthma; flu; croup; bronchitis; sore throat; and lung diseases.
15. A pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous) for use in the treatment of respiratory tract disorders.
16. A pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous) according to claim 15 wherein the respiratory tract disorders are selected from the group consisting of asthma; flu; croup; bronchitis; sore throat; and lung diseases.
17.Use of a pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous) in the preparation of a medicament for the treatment of respiratory tract disorders.
18. Use according to claim 17 wherein the respiratory tract disorders are selected from the group consisting of asthma; flu; croup; bronchitis; sore throat; and lung diseases.
19.A medicament for the treatment of respiratory tract disorders substantially as herein described and exemplified.
20. A pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous) substantially as herein described and exemplified.
21.Use of a pharmaceutically effective amount of coal ash and plant material or a derivative thereof obtained from plants of the species Vernonia glabra (phimatenous) substantially as herein described and exemplified. “TH DATED THIS J... DAY OF SEPTEMBER 2005. I DM KISCH INC PATENT ATTORNEYS FOR THE APPLICANT
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200507552A ZA200507552B (en) | 2004-09-10 | 2005-09-19 | Medicament for the treatment of respiratory tract disorders |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200407288 | 2004-09-10 | ||
| ZA200507552A ZA200507552B (en) | 2004-09-10 | 2005-09-19 | Medicament for the treatment of respiratory tract disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200507552B true ZA200507552B (en) | 2006-07-26 |
Family
ID=38181301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200507552A ZA200507552B (en) | 2004-09-10 | 2005-09-19 | Medicament for the treatment of respiratory tract disorders |
Country Status (1)
| Country | Link |
|---|---|
| ZA (1) | ZA200507552B (en) |
-
2005
- 2005-09-19 ZA ZA200507552A patent/ZA200507552B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sharma et al. | Acorus calamus (The Healing Plant): A review on its medicinal potential, micropropagation and conservation | |
| Lino et al. | Analgesic and antiinflammatory activities of Justicia pectoralis Jacq and its main constituents: coumarin and umbelliferone | |
| Rajvaidhya et al. | A review on Acacia Arabica-an Indian medicinal plant | |
| Gopukumar et al. | Ficus benghalensis Linn–the sacred Indian medicinal tree with potent pharmacological remedies | |
| Mali et al. | Phcog Rev.: Plant review Rakta Kanchan (Bauhinia variegata): Chemistry traditional and medicinal uses—A review | |
| Azeem et al. | Fungi for human health | |
| Toma et al. | Phytochemical screening and toxicity studies of the aqueous extract of the pods pulp of Cassia sieberiana DC.(Cassia Kotchiyana Oliv.) | |
| Deepthi et al. | A comprehensive review of Sesbania grandiflora (L.) Pers: traditional uses, phytochemistry and pharmacological properties | |
| Gopal et al. | Investigation of in-vitro anti-oxidant, anti-inflammatory and anti-arthritic activity of aerial parts of Securinega leucopyrus (Willd.) Muell | |
| Ezin et al. | Azadirachta indica: Its biological, pharmacological, antidiabetic potential, and omics applications | |
| Samuel et al. | Echinacea purpurea-A potent medicinal herb. | |
| Kang et al. | The comparative study of immunomodulatory effect by Glycyrrhiza new varieties and official compendia | |
| Mantena et al. | Anti inflammatory activity of Erythrina Variegata | |
| Kacemi et al. | Bee Pollen as a Source of Pharmaceuticals: Where Are We Now? | |
| ZA200507552B (en) | Medicament for the treatment of respiratory tract disorders | |
| RU2000116660A (en) | BIOLOGICALLY ACTIVE FOOD ADDITIVE | |
| GB9920886D0 (en) | Herbal composition for treatment acene and fungal infection of skin and nails | |
| Sikarwar et al. | Cordia macleodii (Griff.) Hook. f. & Thomson (Boraginaceae)–A comprehensive review | |
| Ugwu et al. | Evaluation of the Antimicrobial Effects of Syzygium aromaticum (Clove) and Garcinia kola (Bitter kola) extracts singly and in Combination, on Some Bacteria | |
| Prashar et al. | A review on Myrica nagi approach in recognizing the overall potential of the plant | |
| Mali et al. | Bauhinia variegata Linn.(Mountain Ebony): A review on ethnobotany, phytochemistry and pharmacology | |
| Narayanan et al. | Coastal sand dune plants as a valuable resource of bioactive metabolites in pharmaceutical field | |
| Nazreen | Ethnomedicinal uses, Pharmacological and phytochemical studies of bambusa arundinaceae retz (a review) | |
| Kikowska et al. | Biotechnological stimulation of phenolics in Lychnis flos-cuculi shoot cultures | |
| Udvardy et al. | A perspective on the anti-infective activity of Goldenseal (Hydrastis Canadensis) and its contribution to the development of multidrug pump inhibitors |